GO:0009072 aromatic amino acid metabolic process: Biosynthesis, Catabolism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0009072 aromatic amino acid metabolic process describes all chemical reactions and pathways involving phenylalanine, tyrosine, and tryptophan, which share an aromatic ring.
• In plants and microorganisms, the shikimate pathway provides the primary route for aromatic amino acid biosynthesis, while mammals must obtain these amino acids from the diet.
• Gut microbial enzymes convert aromatic amino acids into at least nine circulating metabolites that influence host physiology and disease risk.
• Aromatic amino acid decarboxylases and other catabolic enzymes generate neurotransmitters and trace amines with broad biological roles.
• Dysregulation of aromatic amino acid metabolism is linked to diabetes, cardiovascular disease, and neurological disorders.
• CRISPR knockout, knock-in, point mutation, and overexpression models enable causal dissection of aromatic amino acid metabolic genes in health and disease.
Description
Aromatic amino acid metabolic process (GO:0009072) encompasses the chemical reactions and pathways involving phenylalanine, tyrosine, and tryptophan, a family of amino acids characterized by an aromatic ring. These amino acids are not only building blocks of proteins but also precursors for neurotransmitters, hormones, and a wide array of secondary metabolites. The shikimate pathway, present in plants and microorganisms, is the major biosynthetic route for aromatic amino acids, whereas mammals rely on dietary intake and gut microbial metabolism. The importance of this process extends to human health: large-scale metabolomic profiling has linked aromatic amino acids and their derivatives to the risk of developing diabetes, and gut microbe-derived products from aromatic amino acids are associated with cardiovascular morbidity and mortality. In trypanosomatids, aromatic amino acid catabolism supports essential metabolic functions and represents a potential drug target. Recent work has identified an aromatic amino acid exporter, AexB, that functions as a metabolic safety valve, highlighting the dynamic regulation of intracellular aromatic amino acid levels. Understanding the enzymes, transporters, and regulatory mechanisms of aromatic amino acid metabolism is therefore critical for basic biology and translational research.
aromatic amino acid metabolic process At A Glance
| GO ID | GO:0009072 |
|---|---|
| GO term | aromatic amino acid metabolic process |
| Ontology | biological_process |
| Synonym | aromatic amino acid family metabolic process; aromatic amino acid family metabolism |
| Major function | Biosynthesis, catabolism, and interconversion of phenylalanine, tyrosine, and tryptophan |
| Key pathways | Shikimate pathway (biosynthesis); decarboxylation and transamination (catabolism) |
| Taxonomic scope | All domains of life; plants and microbes synthesize, mammals depend on diet and microbiota |
| Related metabolites | Phenylalanine, tyrosine, tryptophan, and their derivatives (e.g., trace amines, indoles) |
What Is GO:0009072?
GO:0009072 aromatic amino acid metabolic process is defined as the chemical reactions and pathways involving the aromatic amino acid family, which includes phenylalanine, tyrosine, and tryptophan. This biological process covers both biosynthesis (e.g., via the shikimate pathway in plants and microbes) and catabolism (e.g., decarboxylation, transamination, and ring modification) of these amino acids, as well as their interconversion and utilization for downstream metabolite production.
Why Is aromatic amino acid metabolic process Important in Cell Biology?
Aromatic amino acid metabolism is central to cellular physiology because it supplies precursors for protein synthesis and for a vast array of bioactive molecules, including neurotransmitters, hormones, and microbial metabolites that modulate host immunity and metabolism. Dysregulation of this process contributes to metabolic and cardiovascular diseases, as evidenced by epidemiological links between aromatic amino acid profiles and diabetes risk and between gut microbial aromatic amino acid catabolites and cardiovascular events. Moreover, the shikimate pathway is absent in humans, making its enzymes attractive targets for antimicrobial and herbicide development. In parasitic trypanosomatids, aromatic amino acid catabolism is essential and differs from host metabolism, offering therapeutic opportunities. The recent discovery of AexB as an aromatic amino acid exporter underscores the importance of transport in maintaining metabolic balance.
• Provides phenylalanine, tyrosine, and tryptophan for protein synthesis and as precursors of neurotransmitters and hormones.
• The shikimate pathway is a validated target for antibiotics, antifungals, and herbicides due to its absence in animals.
• Gut microbial aromatic amino acid metabolism produces nine circulating metabolites that influence host physiology.
• Aromatic amino acid decarboxylases generate trace amines and neurotransmitters with roles in neurological function.
• Altered aromatic amino acid levels are associated with increased risk of type 2 diabetes.
• Gut microbe-derived aromatic amino acid products predict cardiovascular morbidity and mortality.
• In trypanosomatids, aromatic amino acid catabolism is essential and a potential drug target.
• Exporters such as AexB act as metabolic safety valves to prevent toxic accumulation of aromatic amino acids.
• Metabolomic profiling of aromatic amino acids offers biomarkers for disease risk stratification.
• CRISPR-based models enable functional dissection of genes in this pathway for therapeutic development.
What Happens During aromatic amino acid metabolic process?
Biosynthesis via the shikimate pathway
In simple terms: Plants and microbes build aromatic amino acids from simple carbon sources using a dedicated series of enzymatic steps.
The shikimate pathway is the primary biosynthetic route for phenylalanine, tyrosine, and tryptophan in plants and microorganisms. It begins with the condensation of erythrose-4-phosphate and phosphoenolpyruvate and proceeds through seven enzymatic steps to chorismate, the branchpoint precursor for the three aromatic amino acids. Chorismate is then converted to prephenate for phenylalanine and tyrosine biosynthesis, or to anthranilate for tryptophan biosynthesis. These pathways are tightly regulated by feedback inhibition and transcriptional control to balance amino acid supply with demand.
Catabolism by decarboxylases and transaminases
In simple terms: Aromatic amino acids can be broken down by enzymes that remove their carboxyl or amino groups, producing bioactive amines and other metabolites.
Aromatic L-amino acid decarboxylases catalyze the decarboxylation of aromatic amino acids and their derivatives, yielding trace amines and neurotransmitters such as dopamine and serotonin. These enzymes are pyridoxal phosphate-dependent and exhibit broad substrate specificity, with mechanistic features that have been exploited in microbial biotechnology. Transamination reactions, catalyzed by aromatic amino acid aminotransferases, transfer the amino group to alpha-ketoglutarate, generating aromatic keto acids that enter central carbon metabolism. In trypanosomatids, aromatic amino acid catabolism proceeds through unique enzymatic steps that differ from mammalian pathways, providing potential drug targets.
Gut microbial conversion to circulating metabolites
In simple terms: Bacteria in the gut transform aromatic amino acids into a variety of small molecules that enter the bloodstream and affect our health.
The gut microbiota metabolizes aromatic amino acids into at least nine circulating metabolites, including phenylpyruvic acid, 4-hydroxyphenylpyruvic acid, indole-3-lactic acid, and others. These microbial products can act as signaling molecules or toxins, and their levels in blood have been associated with cardiovascular morbidity and mortality. The metabolic fate of aromatic amino acid-derived isomers can be resolved using advanced metabolomics and HDX-HRMS/MS, revealing distinct tautomeric forms with different biological activities. This microbial-host metabolic interplay is a rapidly growing area of research.
Transport and metabolic safety valves
In simple terms: Cells need to export excess aromatic amino acids to avoid toxicity, using specialized transporter proteins.
AexB is an aromatic amino acid exporter that functions as a metabolic safety valve, preventing intracellular accumulation of aromatic amino acids to toxic levels. Such exporters are critical for maintaining metabolic homeostasis, especially in microorganisms that encounter fluctuating nutrient availability. In plants, transporters also play roles in distributing aromatic amino acids between organelles and tissues. The regulation of transport activity is therefore an integral part of aromatic amino acid metabolic process.
Interconversion and downstream utilization
In simple terms: Aromatic amino acids can be converted into one another and used to make many important molecules.
Phenylalanine can be hydroxylated to tyrosine by phenylalanine hydroxylase, linking the two amino acids metabolically. Tyrosine is a precursor for catecholamines, thyroid hormones, and melanin, while tryptophan is the precursor for serotonin, melatonin, and kynurenine pathway metabolites. These interconversions are catalyzed by specific enzymes that are subject to complex regulation. The shikimate pathway also produces precursors for folate, ubiquinone, and other aromatic compounds in plants and microbes.
Key Genes Involved in GO:0009072 aromatic amino acid metabolic process
The following genes encode enzymes, transporters, and regulatory proteins that participate in aromatic amino acid metabolic process across species.
| Gene | Major Role | Research Relevance |
|---|---|---|
| aroA | EPSP synthase in shikimate pathway | Herbicide target; essential for aromatic amino acid biosynthesis in plants and microbes |
| aroB | Dehydroquinate synthase | Catalyzes early step in shikimate pathway |
| aroC | Chorismate synthase | Final step of shikimate pathway; produces chorismate |
| pheA | Chorismate mutase/prephenate dehydratase | Bifunctional enzyme for phenylalanine biosynthesis |
| tyrA | Chorismate mutase/prephenate dehydrogenase | Bifunctional enzyme for tyrosine biosynthesis |
| trpE | Anthranilate synthase component I | First committed step of tryptophan biosynthesis |
| trpD | Anthranilate phosphoribosyltransferase | Tryptophan biosynthesis |
| DDC | Aromatic L-amino acid decarboxylase | Produces dopamine and serotonin; drug target |
| TAT | Tyrosine aminotransferase | Catabolism of tyrosine; links to energy metabolism |
| HGD | Homogentisate 1,2-dioxygenase | Tyrosine catabolism; mutations cause alkaptonuria |
| PAH | Phenylalanine hydroxylase | Converts phenylalanine to tyrosine; mutations cause PKU |
| AexB | Aromatic amino acid exporter | Metabolic safety valve; prevents toxic accumulation |
| TDO2 | Tryptophan 2,3-dioxygenase | Tryptophan catabolism via kynurenine pathway |
| IDO1 | Indoleamine 2,3-dioxygenase | Tryptophan catabolism; immune regulation |
| KMO | Kynurenine 3-monooxygenase | Kynurenine pathway; neuroactive metabolites |
| GOT1 | Glutamic-oxaloacetic transaminase 1 | Transamination of aromatic amino acids |
| GOT2 | Glutamic-oxaloacetic transaminase 2 | Mitochondrial transamination |
How Is aromatic amino acid metabolic process Regulated?
Aromatic amino acid metabolic process is regulated at multiple levels. In plants and microorganisms, the shikimate pathway enzymes are subject to feedback inhibition by end products (phenylalanine, tyrosine, tryptophan) and transcriptional repression via attenuation or repressor proteins. In mammals, dietary protein intake and hormonal signals influence aromatic amino acid availability, while gut microbial metabolism adds an additional layer of regulation. The expression of catabolic enzymes such as aromatic L-amino acid decarboxylase is controlled by tissue-specific transcription factors and alternative splicing. Transporters like AexB are regulated in response to intracellular amino acid levels, acting as safety valves. Post-translational modifications, including phosphorylation, also modulate enzyme activity in response to cellular energy status.
aromatic amino acid metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PAH | Phenylketonuria (PKU) | Knockout mouse or patient-derived iPSCs with point mutations |
| DDC | Aromatic L-amino acid decarboxylase deficiency | Knockout cell lines and knock-in of patient mutations |
| TDO2 | Cancer immune evasion; neurological disorders | Overexpression and knockout in cancer cell lines |
| IDO1 | Immune tolerance; depression | Knockout mice and overexpression models |
| AexB | Metabolic toxicity; bacterial survival | Bacterial knockout and overexpression strains |
Metabolic and cardiovascular disease
Aromatic amino acid metabolites are emerging as biomarkers and mediators of metabolic and cardiovascular disease. Metabolomic profiling has shown that elevated levels of certain aromatic amino acids, such as phenylalanine and tyrosine, are associated with an increased risk of developing type 2 diabetes. Gut microbial catabolism of aromatic amino acids produces circulating metabolites that predict cardiovascular morbidity and mortality, suggesting a causal role for microbial-host co-metabolism in atherosclerosis and thrombosis. These findings highlight the potential for targeting aromatic amino acid metabolic pathways to reduce disease risk.
Neurological and psychiatric disorders
Aromatic amino acids are precursors for neurotransmitters, and their metabolic dysregulation is implicated in neurological and psychiatric conditions. Aromatic L-amino acid decarboxylase deficiency causes a severe neurodevelopmental disorder characterized by dopamine and serotonin deficiency. Tryptophan catabolism via the kynurenine pathway generates neuroactive metabolites that modulate glutamatergic and immune responses, and imbalances have been linked to depression and neurodegeneration. Understanding these pathways may lead to new therapeutic strategies.
Infectious and parasitic diseases
The shikimate pathway is essential in bacteria, fungi, and plants but absent in humans, making it an attractive target for antimicrobial and antiparasitic drugs. In trypanosomatids, aromatic amino acid catabolism is required for survival and virulence, and enzymes in this pathway differ sufficiently from host enzymes to allow selective inhibition. Targeting aromatic amino acid metabolism could therefore yield new treatments for infections caused by Trypanosoma and related parasites.
From aromatic amino acid metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene impair aromatic amino acid biosynthesis? | CRISPR knockout in cell lines or model organisms |
| Does a specific point mutation alter enzyme activity? | CRISPR point mutation knock-in |
| Can a tagged version of the enzyme reveal its localization? | CRISPR knock-in of fluorescent or epitope tags |
| Does overexpression of a transporter reduce toxicity? | CRISPR overexpression (e.g., CRISPRa) or cDNA overexpression |
| Which genes are essential for gut microbial aromatic amino acid metabolism? | CRISPR library screening in bacterial strains |
| How does a disease-associated variant affect metabolic flux? | Isogenic knock-in cell lines and metabolomics |
How to Study the aromatic amino acid metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS metabolomics | Levels of aromatic amino acids and derivatives | Biomarker discovery in diabetes and cardiovascular disease |
| Stable isotope tracing | Metabolic flux through pathways | Quantifying shikimate pathway activity |
| RNA-seq | Gene expression changes | Identifying regulators of aromatic amino acid metabolism |
| CRISPR library screening | Essential genes for growth or survival | Discovering novel metabolic genes in bacteria or cancer cells |
| Enzyme activity assays | Catalytic rate and substrate specificity | Characterizing mutant enzymes |
| HDX-HRMS/MS | Tautomeric resolution of metabolites | Distinguishing biologically active isomers |
| Gnotobiotic animal models | Host-microbe metabolic interactions | Linking microbial aromatic amino acid products to disease |
Metabolomics and flux analysis
Untargeted and targeted metabolomics using LC-MS/MS or GC-MS can quantify aromatic amino acids and their derivatives in cells, tissues, and biofluids. Stable isotope tracing with labeled precursors enables flux analysis through the shikimate and catabolic pathways. Advanced techniques such as HDX-HRMS/MS can resolve tautomeric forms of aromatic amino acid-derived metabolites, providing deeper mechanistic insights.
Genomic and transcriptomic profiling
RNA-seq and microarray analyses reveal expression changes in genes encoding aromatic amino acid metabolic enzymes under different conditions. CRISPR library screening coupled with next-generation sequencing can identify genes required for growth in defined media or for resistance to metabolic inhibitors. These approaches are powerful for discovering novel regulators of the pathway.
Enzyme assays and protein biochemistry
Recombinant enzymes can be purified and assayed for catalytic activity using spectrophotometric or chromatographic methods. Site-directed mutagenesis and CRISPR point mutation models allow structure-function studies. Protein-protein interaction assays, such as co-immunoprecipitation and yeast two-hybrid, can identify regulatory partners.
Microbial and gnotobiotic models
Gut microbial communities can be studied using in vitro fermentation systems or gnotobiotic animals colonized with defined bacterial strains. These models help dissect the contribution of microbial aromatic amino acid metabolism to host physiology and disease. CRISPR-based editing of bacterial genomes enables causal testing of specific microbial genes.
How CRISPR Can Be Used to Study GO:0009072 aromatic amino acid metabolic process
Knockout
CRISPR knockout (KO) is used to completely ablate genes involved in aromatic amino acid metabolism, such as PAH, DDC, or TDO2, to study loss-of-function phenotypes. KO cell lines and animal models help determine whether a gene is essential for biosynthesis, catabolism, or transport. For example, KO of AexB in bacteria can reveal its role in preventing aromatic amino acid toxicity.
Point Mutation
CRISPR point mutation knock-in introduces specific nucleotide changes to model disease-associated variants or to dissect catalytic residues. This approach is ideal for studying missense mutations in enzymes like phenylalanine hydroxylase (PAH) that cause phenylketonuria, or in aromatic L-amino acid decarboxylase (DDC) linked to neurotransmitter deficiency. Point mutations can also be used to test the functional impact of post-translational modification sites.
Knock-in
CRISPR knock-in enables the insertion of reporter tags (e.g., GFP, luciferase) or epitope tags into endogenous loci, allowing real-time monitoring of protein expression, localization, and interactions. Knock-in of a tagged AexB, for instance, can track its membrane localization and dynamics under different metabolic conditions. This strategy is also used to create conditional alleles for tissue-specific studies.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression is used to increase the expression of aromatic amino acid metabolic genes to study gain-of-function effects. Overexpression of transporters or enzymes can rescue metabolic defects or exacerbate toxicity, providing insights into rate-limiting steps. For example, overexpressing a decarboxylase can boost production of trace amines.
How EDITGENE Supports aromatic amino acid metabolic process Research
Researchers studying aromatic amino acid metabolic process-related genes often need to determine whether a candidate gene is causally involved in a specific metabolic or disease phenotype. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation in a wide range of cell types and model organisms.
Contact EDITGENE today to design your custom CRISPR model for aromatic amino acid metabolic process research.
Frequently Asked Questions About aromatic amino acid metabolic process
What is GO:0009072 aromatic amino acid metabolic process?
GO:0009072 is a Gene Ontology biological process term that describes all chemical reactions and pathways involving the aromatic amino acid family, which includes phenylalanine, tyrosine, and tryptophan.
What genes are involved in aromatic amino acid metabolic process?
Key genes include those encoding shikimate pathway enzymes (e.g., aroA, aroB, aroC), aromatic amino acid decarboxylases (DDC), transaminases (TAT, GOT1/2), and transporters (AexB).
Why is aromatic amino acid metabolism important for human health?
It supplies precursors for neurotransmitters and hormones, and its dysregulation is linked to diabetes, cardiovascular disease, and neurological disorders.
How do gut bacteria contribute to aromatic amino acid metabolism?
Gut microbes convert aromatic amino acids into at least nine circulating metabolites that can influence host immunity and disease risk.
What diseases are associated with defects in aromatic amino acid metabolism?
Phenylketonuria (PAH deficiency), aromatic L-amino acid decarboxylase deficiency, and certain cancers and cardiovascular conditions are associated with altered aromatic amino acid metabolism.
What is the shikimate pathway?
The shikimate pathway is a seven-step metabolic route used by plants and microorganisms to synthesize aromatic amino acids; it is absent in humans and is a target for herbicides and antimicrobials.
How can CRISPR be used to study aromatic amino acid metabolism?
CRISPR knockout, knock-in, point mutation, and overexpression models allow researchers to test the causal role of specific genes in metabolic pathways and disease.
What is AexB and why is it important?
AexB is an aromatic amino acid exporter that acts as a metabolic safety valve, preventing toxic accumulation of aromatic amino acids in bacteria.
What methods are used to study aromatic amino acid metabolic process?
Common methods include LC-MS/MS metabolomics, stable isotope tracing, RNA-seq, CRISPR screens, and enzyme activity assays.
Can aromatic amino acid metabolites serve as biomarkers?
Yes, metabolomic profiles of aromatic amino acids and their derivatives have been associated with risk of diabetes and cardiovascular events, suggesting biomarker potential.
Conclusion
Aromatic amino acid metabolic process (GO:0009072) is a fundamental biological pathway with far-reaching implications for protein synthesis, neurotransmission, and host-microbe interactions. The shikimate pathway in plants and microbes, catabolic enzymes in mammals and parasites, and transporters like AexB collectively maintain metabolic homeostasis. Dysregulation of this process contributes to diabetes, cardiovascular disease, and neurological disorders, making it a rich area for therapeutic targeting. CRISPR-based models and advanced metabolomic technologies are poised to accelerate discoveries in this field, and EDITGENE offers the tools and expertise to support such research.
References
- 1. Dodd D et al.. 2017. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites.. Nature 551(7682):648-652 PMID: 29168502
- 2. Maeda H et al.. 2012. The shikimate pathway and aromatic amino Acid biosynthesis in plants.. Annu Rev Plant Biol 63:73-105 PMID: 22554242
- 3. Wang TJ et al.. 2011. Metabolite profiles and the risk of developing diabetes.. Nat Med 17(4):448-53 PMID: 21423183
- 4. Christopher MW et al.. 2024. Divergent Metabolic Fates of Aromatic Amino Acid-Derived Isomers: Insights from Ex Vivo Metabolomics and HDX-HRMS/MS-Based Resolution of Tautomers.. Anal Chem 96(42):16917-16925 PMID: 39374072
- 5. Han SW et al.. 2022. Aromatic L-amino acid decarboxylases: mechanistic features and microbial applications.. Appl Microbiol Biotechnol 106(12):4445-4458 PMID: 35763068
- 6. Nemet I et al.. 2023. Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality.. Eur Heart J 44(32):3085-3096 PMID: 37342006
- 7. Nowicki C et al.. 2008. Aromatic amino acid catabolism in trypanosomatids.. Comp Biochem Physiol A Mol Integr Physiol 151(3):381-390 PMID: 17433885
- 8. Everett BA et al.. 2026. AexB is an aromatic amino acid exporter that functions as a metabolic safety valve.. mBio 17(5):e0023126 PMID: 41930951
